No Data
No Data
Earnings Troubles May Signal Larger Issues for BSM ChemicalLtd (SZSE:300796) Shareholders
bsm chemical (300796.SZ): has cumulatively repurchased 0.95% of the shares.
On November 1st, GeLongHui reported that BSM Chemical (300796.SZ) announced that as of October 31, 2024, the company has repurchased a total of 3,416,800 shares through a dedicated securities account for centralized competitive trading, accounting for 0.95% of the total existing share capital of the company. The highest fill price was 10.03 yuan/share, the lowest fill price was 9.26 yuan/share, and the total fill amount was 33.4878 million yuan (excluding transaction fees).
Besmey: Third quarter report 2024
Bsm chemical (300796.SZ) released its performance for the first three quarters, with a net income of 2.2951 million yuan, a decrease of 97.09%.
bsm chemical (300796.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters totaling 9...
BSM Chemical (300796.SZ): The net income for the first three quarters was 2.2951 million yuan, a year-on-year decrease of 97.09%.
On October 28, Grace Market announced its third quarter report for 2024, achieving revenue of 0.971 billion yuan in the first three quarters of 2024, a year-on-year increase of 108.31%; net income attributable to shareholders of listed companies was 2.2951 million yuan, a year-on-year decrease of 97.09%; net income after deducting non-recurring gains and losses was a loss of 6.4873 million yuan, a year-on-year decrease of 108.63%; basic earnings per share was 0.01 yuan/share.
bsm chemical (300796.SZ): The annual production of 12,100 tons of cyclopentane series green new materials project is expected to be put into use in the near future.
On October 22, BSM Chemical (300796.SZ) stated on the investor interaction platform that the overall construction progress of the "Annual output of 12,100 tons of cyclopentane series green new materials project" is in line with the company's expectations. The equipment is currently in the debugging and trial production stage, and is expected to be put into use in the near future.
No Data
No Data